A detailed history of Lombard Odier Asset Management (Europe) LTD transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Lombard Odier Asset Management (Europe) LTD holds 55,000 shares of ITCI stock, worth $4.59 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
55,000
Previous 60,000 8.33%
Holding current value
$4.59 Million
Previous $4.11 Million 2.14%
% of portfolio
0.26%
Previous 0.28%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$67.99 - $80.84 $339,950 - $404,200
-5,000 Reduced 8.33%
55,000 $4.02 Million
Q2 2024

Aug 14, 2024

BUY
$64.76 - $79.84 $3.89 Million - $4.79 Million
60,000 New
60,000 $4.11 Million

Others Institutions Holding ITCI

About Intra-Cellular Therapies, Inc.


  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $7.88B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Lombard Odier Asset Management (Europe) LTD Portfolio

Follow Lombard Odier Asset Management (Europe) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Europe) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Lombard Odier Asset Management (Europe) LTD with notifications on news.